Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G Ball

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Medicinal Chemistry|September 18, 1992
Development, synthesis, and biological evaluation of (-)-trans-(2S,5S)-2-[3-[(2-oxopropyl)sulfonyl]-4-n-propoxy-5-(3- hydroxypropoxy)-phenyl]-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran, a potent orally active platelet-activating factor (PAF) antagonist and its water-soluble prodrug phosphate esterN N Girotra, T Biftu, M M Ponpipom, et al.
The Journal of Organic Chemistry|August 26, 2000
An efficient preparation of vinamidinium hexafluorophosphate saltsI W Davies, J F Marcoux, J Wu, et al.
Journal of Natural Products|July 1, 1995
Barceloneic acid A, a new farnesyl-protein transferase inhibitor from a Phoma speciesH Jayasuriya, R G Ball, D L Zink, et al.
Journal of Medicinal Chemistry|July 22, 1994
Synthesis of a series of 4-(arylethynyl)-6-chloro-4-cyclopropyl-3,4-dihydroquinazolin-2(1H)-ones as novel non-nucleoside HIV-1 reverse transcriptase inhibitorsT J Tucker, T A Lyle, C M Wiscount, et al.
Journal of Medicinal Chemistry|October 16, 1992
Highly potent, orally active diester macrocyclic human renin inhibitorsA E Weber, M G Steiner, P A Krieter, et al.
Bioorganic & Medicinal Chemistry|September 1, 1994
Conformationally constrained o-tolylpiperazine camphorsulfonamide oxytocin antagonists. Structural modifications that provide high receptor affinity and suggest a bioactive conformationP D Williams, R G Ball, B V Clineschmidt, et al.
Journal of Medicinal Chemistry|August 1, 1997
5-(Piperidin-2-yl)- and 5-(homopiperidin-2-yl)-1,4-benzodiazepines: high-affinity, basic ligands for the cholecystokinin-B receptorJ L Castro, H B Broughton, M G Russell, et al.
Journal of Medicinal Chemistry|February 16, 1996
Controlled modification of acidity in cholecystokinin B receptor antagonists: N-(1,4-benzodiazepin-3-yl)-N'-[3-(tetrazol-5-ylamino) phenyl]ureasJ L Castro, R G Ball, H B Broughton, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Medicinal Chemistry|September 18, 1992
Development, synthesis, and biological evaluation of (-)-trans-(2S,5S)-2-[3-[(2-oxopropyl)sulfonyl]-4-n-propoxy-5-(3- hydroxypropoxy)-phenyl]-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran, a potent orally active platelet-activating factor (PAF) antagonist and its water-soluble prodrug phosphate esterN N Girotra, T Biftu, M M Ponpipom, et al.
The Journal of Organic Chemistry|August 26, 2000
An efficient preparation of vinamidinium hexafluorophosphate saltsI W Davies, J F Marcoux, J Wu, et al.
Journal of Natural Products|July 1, 1995
Barceloneic acid A, a new farnesyl-protein transferase inhibitor from a Phoma speciesH Jayasuriya, R G Ball, D L Zink, et al.
Journal of Medicinal Chemistry|July 22, 1994
Synthesis of a series of 4-(arylethynyl)-6-chloro-4-cyclopropyl-3,4-dihydroquinazolin-2(1H)-ones as novel non-nucleoside HIV-1 reverse transcriptase inhibitorsT J Tucker, T A Lyle, C M Wiscount, et al.
Journal of Medicinal Chemistry|October 16, 1992
Highly potent, orally active diester macrocyclic human renin inhibitorsA E Weber, M G Steiner, P A Krieter, et al.
Bioorganic & Medicinal Chemistry|September 1, 1994
Conformationally constrained o-tolylpiperazine camphorsulfonamide oxytocin antagonists. Structural modifications that provide high receptor affinity and suggest a bioactive conformationP D Williams, R G Ball, B V Clineschmidt, et al.
Journal of Medicinal Chemistry|August 1, 1997
5-(Piperidin-2-yl)- and 5-(homopiperidin-2-yl)-1,4-benzodiazepines: high-affinity, basic ligands for the cholecystokinin-B receptorJ L Castro, H B Broughton, M G Russell, et al.
Journal of Medicinal Chemistry|February 16, 1996
Controlled modification of acidity in cholecystokinin B receptor antagonists: N-(1,4-benzodiazepin-3-yl)-N'-[3-(tetrazol-5-ylamino) phenyl]ureasJ L Castro, R G Ball, H B Broughton, et al.
Pageof 2